Provided By PR Newswire
Last update: Apr 28, 2025
SOUTH SAN FRANCISCO, Calif., April 28, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in the upcoming investor relations events.
Read more at prnewswire.comNASDAQ:IDYA (10/30/2025, 12:52:34 PM)
32.23
+0.05 (+0.16%)
Find more stocks in the Stock Screener


